Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.

Kikuchi-Koike R, Nagasaka K, Tsuda H, Ishii Y, Sakamoto M, Kikuchi Y, Fukui S, Miyagawa Y, Hiraike H, Kobayashi T, Kinoshita T, Kanai Y, Shibata T, Imoto I, Inazawa J, Matsubara O, Ayabe T.

BMC Cancer. 2019 May 30;19(1):521. doi: 10.1186/s12885-019-5737-7.

2.

No Effect of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Subjects: Utility of Oita Combination for Clinical Drug-Drug Interaction Study.

Otani N, Wakuda H, Imai H, Kuranari M, Ishii Y, Ito Y, Okubo A, Ogawa O, Takeda K, Ohyama T, Hasunuma T, Uemura N.

Clin Transl Sci. 2019 Sep;12(5):513-518. doi: 10.1111/cts.12646. Epub 2019 Jun 4.

3.

Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitis.

Suzuki S, Sakurai D, Sakurai T, Yonekura S, Iinuma T, Okuma Y, Ihara F, Arai T, Hanazawa T, Fukuda-Kawaguchi E, Ishii Y, Okamoto Y.

Allergol Int. 2019 Jul;68(3):352-362. doi: 10.1016/j.alit.2019.02.003. Epub 2019 Feb 22.

4.

Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.

Kanzawa T, Hirai T, Fukuda H, Katsumata H, Ishii R, Ikemiyagi M, Ishii Y, Saiga K, Okumi M, Tanabe K.

Acta Diabetol. 2019 May;56(5):541-550. doi: 10.1007/s00592-019-01289-7. Epub 2019 Feb 13.

PMID:
30758788
5.

Evaluation of the impact of conventional immunosuppressant on the establishment of murine transplantation tolerance - an experimental study.

Katsumata H, Miyairi S, Ikemiyagi M, Hirai T, Fukuda H, Kanzawa T, Ishii R, Saiga K, Ishii Y, Omoto K, Okumi M, Yokoo T, Tanabe K.

Transpl Int. 2019 Apr;32(4):443-453. doi: 10.1111/tri.13390. Epub 2019 Jan 23.

PMID:
30561097
6.

Impact of activated invariant natural killer T cells on the expansion of regulatory T cell precursors in murine thymocytes in vitro.

Katsumata H, Ikemiyagi M, Hirai T, Kanzawa T, Ishii R, Miyairi S, Fukuda H, Saiga K, Okumi M, Ishii Y, Yokoo T, Tanabe K.

Immunol Lett. 2019 Feb;206:41-48. doi: 10.1016/j.imlet.2018.11.013. Epub 2018 Nov 29.

PMID:
30503823
7.

Targeted ablation of p38α MAPK suppresses denervation-induced muscle atrophy.

Yuasa K, Okubo K, Yoda M, Otsu K, Ishii Y, Nakamura M, Itoh Y, Horiuchi K.

Sci Rep. 2018 Jun 13;8(1):9037. doi: 10.1038/s41598-018-26632-w.

8.

Clinical Drug-Drug Interaction Potential of BFE1224, Prodrug of Antifungal Ravuconazole, Using Two Types of Cocktails in Healthy Subjects.

Ishii Y, Ito Y, Matsuki S, Sanpei K, Ogawa O, Takeda K, Schuck EL, Uemura N.

Clin Transl Sci. 2018 Sep;11(5):477-486. doi: 10.1111/cts.12557. Epub 2018 May 16.

9.

Liposomal α-galactosylceramide is taken up by gut-associated lymphoid tissue and stimulates local and systemic immune responses.

Kaneko K, McDowell A, Ishii Y, Hook S.

J Pharm Pharmacol. 2017 Dec;69(12):1724-1735. doi: 10.1111/jphp.12814. Epub 2017 Sep 5.

PMID:
28872688
10.

Characterization and evaluation of stabilized particulate formulations as therapeutic oral vaccines for allergy.

Kaneko K, McDowell A, Ishii Y, Hook S.

J Liposome Res. 2018 Dec;28(4):296-304. doi: 10.1080/08982104.2017.1370472. Epub 2017 Sep 5.

PMID:
28826286
11.

iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model.

Ishii R, Hirai T, Miyairi S, Omoto K, Okumi M, Ishii Y, Tanabe K.

Am J Transplant. 2018 Feb;18(2):328-340. doi: 10.1111/ajt.14453. Epub 2017 Sep 15.

12.

Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance.

Miyairi S, Hirai T, Ishii R, Okumi M, Nunoda S, Yamazaki K, Ishii Y, Tanabe K.

Eur J Immunol. 2017 Apr;47(4):734-742. doi: 10.1002/eji.201646670. Epub 2017 Mar 21.

13.

Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.

Chen YB, Efebera YA, Johnston L, Ball ED, Avigan D, Lekakis LJ, Bachier CR, Martin P, Duramad O, Ishii Y, Han S, Jung YJ, Lee D, Kunkel L, Negrin RS, Bui JD.

Biol Blood Marrow Transplant. 2017 Apr;23(4):625-634. doi: 10.1016/j.bbmt.2017.01.069. Epub 2017 Jan 16.

14.

Adaptability of Napiergrass (Pennisetum purpureum Schumach.) for Weed Control in Site of Animals Buried after Foot-and-Mouth Disease Infection.

Ishii Y, Iki Y, Inoue K, Nagata S, Idota S, Yokota M, Nishiwaki A.

Scientifica (Cairo). 2016;2016:6532160. doi: 10.1155/2016/6532160. Epub 2016 May 4.

15.

Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation.

Matsuoka S, Ishii Y, Nakao A, Abe M, Ohtsuji N, Momose S, Jin H, Arase H, Sugimoto K, Nakauchi Y, Masutani H, Maeda M, Yagita H, Komatsu N, Hino O.

PLoS One. 2016 Mar 30;11(3):e0150496. doi: 10.1371/journal.pone.0150496. eCollection 2016.

16.

Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in lung granulomas of mice with acute silicosis.

Shimizu Y, Dobashi K, Nagase H, Ohta K, Sano T, Matsuzaki S, Ishii Y, Satoh T, Koka M, Yokoyama A, Ohkubo T, Ishii Y, Kamiya T.

J Clin Biochem Nutr. 2015 Jan;56(1):74-83. doi: 10.3164/jcbn.14-44. Epub 2014 Nov 28.

17.

KLRG+ invariant natural killer T cells are long-lived effectors.

Shimizu K, Sato Y, Shinga J, Watanabe T, Endo T, Asakura M, Yamasaki S, Kawahara K, Kinjo Y, Kitamura H, Watarai H, Ishii Y, Tsuji M, Taniguchi M, Ohara O, Fujii S.

Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12474-9. doi: 10.1073/pnas.1406240111. Epub 2014 Aug 12.

18.

Blood-brain barrier pharmacoproteomics-based reconstruction of the in vivo brain distribution of P-glycoprotein substrates in cynomolgus monkeys.

Uchida Y, Wakayama K, Ohtsuki S, Chiba M, Ohe T, Ishii Y, Terasaki T.

J Pharmacol Exp Ther. 2014 Sep;350(3):578-88. doi: 10.1124/jpet.114.214536. Epub 2014 Jun 19.

PMID:
24947467
19.

Terpendole E and its derivative inhibit STLC- and GSK-1-resistant Eg5.

Tarui Y, Chinen T, Nagumo Y, Motoyama T, Hayashi T, Hirota H, Muroi M, Ishii Y, Kondo H, Osada H, Usui T.

Chembiochem. 2014 May 5;15(7):934-8. doi: 10.1002/cbic.201300808. Epub 2014 Mar 19.

PMID:
24648249
20.

Supplemental Content

Loading ...
Support Center